| NCT ID | NCT06603415 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sohag University |
| Condition | Hashimoto's Thyroiditis |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-07-15 |
| Primary Completion | 2025-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-07-15 with a primary completion date of 2025-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to evaluate the pathological pattern, characteristic features, treatment, complications and prognosis of Hashimoto's thyroiditis in upper Egypt.
Eligibility Criteria
Inclusion Criteria: * All patients with Hashimoto's thyroiditis, males or females, any age, at upper egypt . Exclusion Criteria: * Patients with associated other thyroid pathology other than Hashimoto's thyroiditis.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06603415 clinical trial?
This trial is open to participants of all sexes, studying Hashimoto's Thyroiditis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06603415 currently recruiting?
Yes, NCT06603415 is actively recruiting participants. Contact the research team at hossam.araby07@gmail.com for enrollment information.
Where is the NCT06603415 trial being conducted?
This trial is being conducted at Sohag, Egypt, Sohag, Egypt.
Who is sponsoring the NCT06603415 clinical trial?
NCT06603415 is sponsored by Sohag University. The trial plans to enroll 30 participants.